A new visual rating scale for Ioflupane imaging in Lewy body disease

BACKGROUND: Dopaminergic loss on (123)I-Ioflupane brain imaging is a recognised biomarker for dementia with Lewy bodies. It is usually assessed using a visual rating scale developed for Parkinson's disease, which may not be optimal for dementia with Lewy bodies, as patterns of dopaminergic loss...

Descripción completa

Detalles Bibliográficos
Autores principales: Lloyd, Jim J., Petrides, George, Donaghy, Paul C., Colloby, Sean J., Attems, Johannes, O'Brien, John T., Roberts, Gemma, Thomas, Alan J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6169248/
https://www.ncbi.nlm.nih.gov/pubmed/30268991
http://dx.doi.org/10.1016/j.nicl.2018.09.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6169248/
https://www.ncbi.nlm.nih.gov/pubmed/30268991
http://dx.doi.org/10.1016/j.nicl.2018.09.012

Ejemplares similares